Global Post-Marketing Pharmacovigilance And Medical Information Market is
expected to reach USD 5.3 Billion by 2022, according to a new report by Grand
View Research, Inc. Increasing prevalence of Adverse Drug Reactions (ADRs)
coupled with incorporation of advanced ADR reporting tools is responsible for
the overall growth of the post-marketing pharmacovigilance and medical
information market. Increased drug consumption can be attributed to rising
prevalence of chronic diseases such as tuberculosis that involve multiple drug
regimes.
Rising government initiatives for improvement of
pharmacovigilance services and maintenance of medical databases are also
responsible for inducing overall growth of post-marketing pharmacovigilance and
medical information market. For instance, in December 2015, the USAID Systems
for Improved Access to Pharmaceuticals and Services (SIAPS) launched PViMS tool
to improve drug safety monitoring in low- and middle-income countries by
helping clinicians, researchers, and regulatory authorities to collect,
analyze, and monitor ADRs.
Browse Details of Report@ http://www.grandviewresearch.com/industry-analysis/post-marketing-pharmacovigilance-medical-information-market
Further key findings from the study
suggest:
- Spontaneous reporting dominated the post-marketing
pharmacovigilance market in terms of revenue share as of 2014 and
accounted for over 30.0% of market owing to wide usage in reporting of
unknown and suspected ADRs. Preference of healthcare professionals and
researchers towards this method is also responsible for the overall growth
of this segment.
- Cohort event monitoring is anticipated to be the
fastest growing in post-marketing pharmacovigilance owing to application
in all types of clinical events. Moreover, associated benefits such as
early detection, high accuracy, and cost-efficiency are also anticipated
to be the growth inducing factors.
- Books dominated the overall product segment in terms
of revenue share as of 2014 owing to the preference by clinicians and
healthcare professionals as a primary source of information pertaining to
adverse drug reactions. Online media is anticipated to be the fastest
growing segment with a CAGR of over 13.0 % during the forecast period
owing to rising inclination towards digitalized data.
- Hospitals held the dominant share of end-use segment
as a consequence of low costs associated with hospital based
post-marketing pharmacovigilance surveillance. Research organizations
segment is anticipated to show significant growth rate in coming years
owing to streamlining of R&D in developing of new medicines and
improving risk management through early prognosis of ADRs.
- The key players of post-marketing pharmacovigilance
and medical information market include Accenture Plc., Clinquest Group
B.V., Cognizant Technology Solutions Corporation, Covance, Inc.,
iMEDGlobal Corporation, inVentiv Health Clinical, Parexel International
Corporation, Pharmaceutical Product Development, Inc., PRA Health
Sciences, Inc., Quintiles, F. Hoffmann-La Roche Ltd., Sanofi Aventis,
Synowledge LLC, Wipro Ltd., ArisGlobal, Ergomed Plc. Rising strategic
alliances and mergers &acquisitions are also anticipated to drive
market growth. For instance, in January 2016, strategic collaboration of
Parexel and Optum for reducingcosts related to post-approval studies and
spreading awareness among the population base.
Grand View Research has segmented the global
post-marketing pharmacovigilance and medical information market on the basis of
type, product, end-useand region:
Global post-marketing
pharmacovigilance type outlook (Revenue, USD Million, 2012 - 2022)
- Spontaneous Reporting
- Intensified ADR Reporting
- Targeted Spontaneous Reporting
- Cohort Event Monitoring
- EHR Mining
Global post-marketing
pharmacovigilance and medical information product outlook(Revenue, USD Million,
2012 - 2022)
- Books
- Online Media
- Journals
Global post-marketing
pharmacovigilance and medical information end-use outlook (Revenue, USD
Million, 2012 - 2022)
- Hospitals
- Research Organizations
- Others
Post-marketing pharmacovigilance and
medical information regional outlook (Revenue, USD Million, 2012 - 2022)
- North America
- U.S.
- Canada
- Europe
- UK
- Germany
- France
- Asia Pacific
- Japan
- China
- India
- Latin America
- Mexico
- Brazil
- MEA
- South Africa
About Grand View Research
Grand View Research, Inc. is a U.S.
based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides
syndicated research reports, customized research reports, and consulting
services. To help clients make informed business decisions, we offer market
intelligence studies ensuring relevant and fact-based research across a range of
industries, from technology to chemicals, materials and healthcare.
No comments:
Post a Comment